未述之事:股浅动脉与腘动脉慢性完全闭塞内膜下血管成形术的早期与中期结果
该回顾性分析纳入2018至2021年450例慢性肢体缺血患者,比较股浅动脉(n=260)与腘动脉(n=190)慢性完全闭塞行内膜下血管成形术的即刻与中期结果。腘动脉组技术成功率更高(96.3% vs 91.2%,p=0.03),但股浅动脉组1年肢体通畅率、无截肢生存率和伤口愈合率更优。流出道血管数量是肢体通畅丧失的唯一相关因素(HR 0.055,95%CI 0.001-3.020,p=0.039)。
要点
- 腘动脉组技术成功率高于股浅动脉组(96.3% vs 91.2%,p=0.03)。
- 股浅动脉组1年肢体通畅率优于腘动脉组(82% vs 43%,p=0.006)。
- 流出道血管数量与肢体通畅丧失相关(HR 0.055,95%CI 0.001-3.020)。
核心结论
- 内膜下血管成形术是股浅动脉和腘动脉慢性完全闭塞有效且安全的内血管治疗选择,即刻结果满意。
- 中期结果股浅动脉病变更优,表现为肢体通畅率、无截肢生存率和伤口愈合率改善。
研究设计与样本
- 回顾性分析2018至2021年慢性肢体缺血(Rutherford 3-6级)患者,股浅动脉或腘动脉慢性完全闭塞接受内膜下血管成形术及选择性支架植入。
- 共450例患者,股浅动脉组260例(57.8%),腘动脉组190例(42.2%)。
- 比较两组即刻结果(技术成功、围手术期并发症、30天重大截肢和死亡率)及技术成功手术的中期结果(肢体通畅、伤口愈合率、无截肢生存率、主要不良肢体事件)。
主要发现
- 股浅动脉组血运重建指征为慢性肢体威胁性缺血者占80.8%,腘动脉组占84.2%。
- 腘动脉组技术成功率高于股浅动脉组(96.3% vs 91.2%,p=0.03)。
- 股浅动脉组与腘动脉组30天截肢率相当(7.7% vs 6.8%,p=0.7)。
- 本研究无围手术期死亡或全身重大并发症发生。
- Kaplan-Meier估计1年结果股浅动脉组显著更优:肢体通畅率82% vs 43%(p=0.006),无截肢生存率88% vs 64%(p=0.02),伤口愈合率79% vs 58%(p=0.027)。
临床怎么用
- 内膜下血管成形术是内血管外科医生武器库中有价值的工具,因为再入装置并非总是广泛可及。
- 本研究旨在评估腹股沟下慢性完全闭塞外周血管干预的技术结果,并识别内膜下血管成形术成功的可能预测因素。
- 内膜下血管成形术是腹股沟下慢性完全闭塞的有效治疗选择,腘动脉病变与股浅动脉病变的即刻结果存在差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aims to compare the immediate and mid-term outcomes of subintimal angioplasty (SIA) of chronic total occlusions (CTOs) of superficial femoral artery (SFA) versus popliteal artery (PA) and to identify possible predictors of loss of limb-based patency (LBP). METHODS: This is a retrospective analysis of chronic lower-limb ischemia (CLI) patients (Rutherford classes 3-6) presenting with CTO of SFA or PA treated by SIA and selective stenting in the period 2018 to 2021. Immediate outcomes were compared between the SFA and PA groups, including technical success, perioperative complications, and 30-day major amputation and mortality rates. Mid-term outcomes for technically successful procedures included limb-based patency (LBP), wound healing rate, amputation-free survival (AFS), and major adverse limb events (MALEs). RESULTS: A total of 450 CLI patients underwent SIA of CTO at the SFA (n=260, 57.8%) and the PA (n=190, 42.2%). The indication for revascularization was chronic limb-threatening ischemia in 80.8% of SFA group and 84.2% of PA group. Technical success rate was higher in the PA group compared to the SFA group (96.3% vs 91.2%; p=0.03). The 30-day amputation rates were comparable between the SFA and PA groups (7.7% vs 6.8%, p=0.7, respectively). No perioperative mortality or systemic major complications occurred in the present study. Kaplan-Meier estimate of the 1-year rates were significantly better for SFA group regarding LBP (82% for SFA group vs 43% for PA group, p=0.006), AFS (88% vs 64%, p=0.02), and wound healing (79% vs 58%, p=0.027), respectively. The number of runoff vessels was the only factor associated with loss of LBP (hazard ratio [HR], 0.055; 95% confidence interval [CI]: 0.001-3.020, p=0.039). CONCLUSIONS: Subintimal angioplasty is an effective and safe endovascular treatment option of CTO at SFA and PA with satisfactory immediate outcomes. The mid-term outcomes, however, are better for SFA lesions in terms of improved LBP, AFS, and wound healing rates. CLINICAL IMPACT: Subintimal angioplasty is a valuable tool in the armamentarium of endovascular surgeons, as re-entry devices aren't always widely accessible. This study aims to assess the technical outcomes of peripheral vascular interventions for infrainguinal chronic total occlusions and identify possible predictors for successful subintimal angioplasty .Subintimal angioplasty is an effective treatment option for infrainguinal CTO with difference in result of immediate outcomes in popliteal lesions and SFA lesions.
引用
- Shahat M, Ali SH, Hussein AN, et al. The Untold Story: Early and Mid-Term Results of Subintimal Angioplasty in Superficial Femoral Artery Versus Popliteal Artery Chronic Total Occlusion. J Endovasc Ther. 2024. PMID: 39320129. doi:10.1177/15266028241281269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。